Patent ID: 7470509

Claim:
A method for determining whether a combination of paclitaxel and cisplatin can be used to reduce the growth of ovarian cancer, comprising the steps of: a. Obtaining a sample of ovarian cancer cells; b. Determining the level of expression in the ovarian cancer cells of each of the markers in the marker set identified in a table selected from the group consisting of: Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9, Table 10, Table 11, Table 12, Table 13, Table 14, and Table 15; and c. Evaluating the expression profile of the marker set, wherein over-expression as compared to expression in normal ovarian cells of the sensitivity markers identified in the table and under-expression as compared to expression in normal ovarian cells of the resistance markers identified in the table indicates that a combination of paclitaxel and cisplatin can be used.